| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Commentary on “Comprehensive Review of Sentinel Lymphadenectomy in Breast Cancer”
|
Reintgen, Douglas
|
|
2000
|
1 |
2 |
p. 126-
1 p.
|
article
|
| 2 |
Commentary on “Internet Usage Among Women with Breast Cancer: An Exploratory Study”
|
Burstein, Harold J.
|
|
2000
|
1 |
2 |
p. 154-155
2 p.
|
article
|
| 3 |
Commentary on “Paclitaxel, 5-Fluorouracil, and Leucovorin (TFL) in the Treatment of Metastatic Breast Cancer”
|
Seidman, Andrew
|
|
2000
|
1 |
2 |
p. 144-
1 p.
|
article
|
| 4 |
Commentary on “Prophylactic Surgery for Women at High Risk for Breast Cancer”
|
Garber, Judy
|
|
2000
|
1 |
2 |
p. 135-
1 p.
|
article
|
| 5 |
Commentary on “Role of 2-[18F]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) in the Early Assessment of Response to Chemotherapy in Metastatic Breast Cancer Patients”
|
Rosen, Eric
|
|
2000
|
1 |
2 |
p. 162-163
2 p.
|
article
|
| 6 |
Comprehensive Review of Sentinel Lymphadenectomy in Breast Cancer
|
Kelemen, Pond R.
|
|
2000
|
1 |
2 |
p. 111-125
15 p.
|
article
|
| 7 |
Docetaxel in Combination with Epirubicin as Neoadjuvant Therapy in Operable Breast Cancer
|
|
|
2000
|
1 |
2 |
p. 107-108
2 p.
|
article
|
| 8 |
HER2 Gene Amplification by Fluorescence In Situ Hybridization(FISH) as a Predictor of Response to Trastuzumab in Metastatic Breast Cancer
|
|
|
2000
|
1 |
2 |
p. 105-106
2 p.
|
article
|
| 9 |
2000 Highlights from: 36th Annual ASCO Meeting; New Orleans, LA May, 2000
|
|
|
2000
|
1 |
2 |
p. 96-102
7 p.
|
article
|
| 10 |
Internet Usage Among Women with Breast Cancer: An Exploratory Study
|
Pereira, Jose L.
|
|
2000
|
1 |
2 |
p. 148-153
6 p.
|
article
|
| 11 |
Letter to the Editor
|
Patridge, Ann
|
|
2000
|
1 |
2 |
p. 164-165
2 p.
|
article
|
| 12 |
Paclitaxel, 5-Fluorouracil, and Leucovorin (TFL) in the Treatment of Metastatic BreastCancer
|
Nicholson, Brenda P.
|
|
2000
|
1 |
2 |
p. 136-143
8 p.
|
article
|
| 13 |
Prophylactic Surgery for Women at High Risk for Breast Cancer
|
Blanchard, Kay D.
|
|
2000
|
1 |
2 |
p. 127-134
8 p.
|
article
|
| 14 |
Role of 2-[18F]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) in the Early Assessment of Response to Chemotherapy in Metastatic Breast Cancer Patients
|
Gennari, Alessandra
|
|
2000
|
1 |
2 |
p. 156-161
6 p.
|
article
|
| 15 |
The EORTC Strategy for the Early 2000's
|
Piccart, M.J.
|
|
2000
|
1 |
2 |
p. 166-167
2 p.
|
article
|
| 16 |
The Future of Clinical Research in Breast Cancer: Opportunities
|
Sledge Jr., George W.
|
|
2000
|
1 |
2 |
p. 95-
1 p.
|
article
|
| 17 |
Trastuzumab as First-Line Therapy of Metastatic Breast Cancer
|
|
|
2000
|
1 |
2 |
p. 103-104
2 p.
|
article
|
Journal description